Slide 1TREATING LIPIDS FOR PREVENTION OF CAD : HOW AGGRESSIVE SHOULD WE BE? Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full…
Slide 1 Attualità nellimpiego delle statine Prof. P. Pauletto Dip. di Medicina Clinica e Sperimentale Università degli Studi di Padova U.O. di Medicina Interna I^ U.L.S.S.…
1. Cardiovascular Epidemiologyand PreventionNathan D. Wong, PhD, FACC, FAHAProfessor and Director, Heart DiseasePrevention Program, Division ofCardiology, University of California,…
1. Cardiovascular Epidemiology: Definitions Historical Perspectives and Assessing Risk of CVD Recent trends and population differences in CHD and CHD risk factors 2. ATotal…
1. Lipid lowering therapy in CKDWhat is the evidence? Conall O’ Seaghdha Renal Meeting Royal North Shore Hospital 29/08/07 2. Case for Discussion 72 male type II DM ESKD…
HYPERTENSION AND DIABETES: THE TWO TERRORISTS TOGETHER Kyaw Soe Win MBBS, MMedSc (Int Med), MRCPUK, FRCP (Edin), FAsCC, FAPSIC Hot Topic in Cardiology 2014 Sedona Hotel 23rd…
1. Primary Prevention ofCardiovascular Disease:the role of aspirin and statins Michael Pignone, MD, MPH Professor of Medicine UNC Division of General Internal Medicine UCSF…
Slide 1Cardiovascular Epidemiology and Prevention Nathan D. Wong, PhD, FACC, FAHA Professor and Director, Heart Disease Prevention Program, Division of Cardiology, University…
Slide 1 HDL: Still a target for therapy? PaACC Annual Chapter Meeting November 2, 2008 Daniel J. Rader, MD University of Pennsylvania School of Medicine [email protected]…